Clinical Trial Update: (Ro 24-2027) A Randomized, Double-Blind, Comparative Study of Dideoxycytidine (ddC) Versus Zidovudine (AZT) in Patients With AIDS or Advanced ARC [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind study compared dideoxycytidine (ddC) with zidovudine (AZT) in patients with AIDS or advanced AIDS-related complex. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Dideoxycytidine (zalcitabine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED